Insulin Degludec Titration Using Mobile Insulin Dosing System

计划入组 240 人 · 首次发布于 2017 年 3 月 27 日

A RANDOMIZED, MULTINATIONAL, DOUBLE-BLIND, PLACEBO-CONTROLLED AND PARALLEL-GROUP ACTIVE COMPARATOR STUDY TO EXAMINE THE SAFETY, TOLERABILITY AND EFFICACY OF ROFECOXIB OF 50 AND 25 MG FOR THE ACUTE TREATMENT OF MIGRAINE

计划入组 0 人

A Randomized, Double Blind, Parallel Group, Placebo Controlled Outpatient Study to Examine the Safety, Tolerability and Efficacy of Single Oral Doses of Rizatriptan 10 mg and Zolmitriptan 2.5 mg for the Acute Treatment of Migraine.

计划入组 0 人

CHROMOPHORE (GLU-TYR-GLY)

C₁₆H₁₅N₃O₆

OL3

Chromophore (Gly-Tyr-Gly)

C₁₅H₁₇N₃O₅

Glo Science, Inc.

United States

White Glo USA Inc

United States

AceLink's Oral GCS Inhibitor Shows Promising Phase 2 Results in Fabry Disease Treatment

Rani Therapeutics Achieves Bioequivalence with Oral GLP-1/GLP-2 Dual Agonist for Obesity Treatment

Rani Therapeutics Launches Phase 1 Trial of Oral GLP-1/GLP-2 Dual Agonist RT-114 for Obesity Treatment